Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: Is it essential for patients with ypT0‐2N0?
Authors:
- 6 July 2009
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 100 (5) , 387-391
Abstract
Background The potential advantage of adjuvant chemotherapy in patients with ypT0‐2N0 rectal cancer remains unclear. The purpose of this study was to evaluate whether this therapy has an impact on survival. Materials and Methods Patients who underwent curative surgery after preoperative chemoradiation for locally advanced low rectal cancer were retrospectively reviewed. A total of 41 consecutive patients with pathological stage 0 (ypT0N0) or I (ypT1‐2N0) were enrolled. Of the 41 patients, 17 (41.5%) received postoperative 5‐fluorouracil (5‐FU)‐based chemotherapy, while 24 were followed without postoperative therapy. Oncologic outcomes were compared between the two groups. Results The median follow‐up period was 47.6 months. The overall postoperative complication rates did not differ significantly between the patients who received chemotherapy and those who did not (17.6% vs. 20.8%, P = 0.799). The 5‐year overall and disease‐free survival rates for patients who received chemotherapy were 88.9% and 84.7%, which were not significantly different from the rates for those who did not (85.9%; P = 0.644 and 73.4%; P = 0.599, respectively). Conclusions Postoperative adjuvant chemotherapy for patients with good responses after preoperative chemoradiation and curative surgery did not significantly improve the survival. However, this should be validated in prospective randomized trials with larger sample sizes. J. Surg. Oncol. 2009;100:387–391.Keywords
This publication has 23 references indexed in Scilit:
- Absence of Lymph Nodes in the Resected Specimen After Radical Surgery for Distal Rectal Cancer and Neoadjuvant Chemoradiation Therapy: What does it Mean?Diseases of the Colon & Rectum, 2008
- Patients With Curative Resection of cT3-4 Rectal Cancer After Preoperative Radiotherapy or Radiochemotherapy: Does Anybody Benefit From Adjuvant Fluorouracil-Based Chemotherapy? A Trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology GroupJournal of Clinical Oncology, 2007
- Postoperative Chemotherapy May Not Be Necessary for Patients With ypN0-Category After Neoadjuvant Chemoradiotherapy of Rectal CancerDiseases of the Colon & Rectum, 2006
- Long-term Oncologic Outcome Following Preoperative Combined Modality Therapy and Total Mesorectal Excision of Locally Advanced Rectal CancerAnnals of Surgery, 2005
- Practice Parameters for the Management of Rectal Cancer (Revised)Diseases of the Colon & Rectum, 2005
- Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survivalJournal of Gastrointestinal Surgery, 2005
- Preoperative versus Postoperative Chemoradiotherapy for Rectal CancerNew England Journal of Medicine, 2004
- Improved Sphincter Preservation in Low Rectal Cancer With High-Dose Preoperative Radiotherapy: The Lyon R96-02 Randomized TrialJournal of Clinical Oncology, 2004
- A Pathologic Complete Response to Preoperative Chemoradiation Is Associated With Lower Local Recurrence and Improved Survival in Rectal Cancer Patients Treated by Mesorectal ExcisionDiseases of the Colon & Rectum, 2003
- Complete Response to Neoadjuvant Chemoradiation for Rectal Cancer Does Not Influence SurvivalAnnals of Surgical Oncology, 2001